The status of Nrf2-based therapeutics: current perspectives and future prospects
This mini-review presents the authors' vision on the current status and future trends in the development of neuroprotective agents working via activation of nuclear factor erythroid 2-related factor 2 (Nrf2), and in particular, via disruption of Nrf2-Keap1 interaction. There are two opposite “c...
Main Authors: | Irina G Gazaryan, Bobby Thomas |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Neural Regeneration Research |
Subjects: | |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2016;volume=11;issue=11;spage=1708;epage=1711;aulast=Gazaryan |
Similar Items
-
Nordihydroguaiaretic Acid: From Herbal Medicine to Clinical Development for Cancer and Chronic Diseases
by: Gina Manda, et al.
Published: (2020-02-01) -
Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer
by: Pelin Telkoparan-Akillilar, et al.
Published: (2021-03-01) -
The Nrf2 System as a Potential Target for the Development of Indirect Antioxidants
by: Mi-Kyoung Kwak, et al.
Published: (2010-10-01) -
Identification of novel indole derivatives acting as inhibitors of the Keap1–Nrf2 interaction
by: Barbara Cosimelli, et al.
Published: (2019-01-01) -
Challenges and Limitations of Targeting the Keap1-Nrf2 Pathway for Neurotherapeutics: Bach1 De-Repression to the Rescue
by: Dmitry M. Hushpulian, et al.
Published: (2021-04-01)